A genome-wide association study for late-onset Alzheimer's disease using DNA pooling

[1]  M C O'Donovan,et al.  A genome-wide association study in 574 schizophrenia trios using DNA pooling , 2009, Molecular Psychiatry.

[2]  P. Visscher,et al.  Highly cost-efficient genome-wide association studies using DNA pools and dense SNP arrays , 2008, Nucleic acids research.

[3]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[4]  S. Lovestone,et al.  Diagnosing Alzheimer's disease—non‐clinicians and computerised algorithms together are as accurate as the best clinical practice , 2007, International journal of geriatric psychiatry.

[5]  M. Gill,et al.  Association studies of 23 positional/functional candidate genes on chromosome 10 in late‐onset Alzheimer's disease , 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[7]  Pauline C Ng,et al.  Power to Detect Risk Alleles Using Genome-Wide Tag SNP Panels , 2007, PLoS genetics.

[8]  Robert Plomin,et al.  Applicability of DNA pools on 500 K SNP microarrays for cost-effective initial screens in genomewide association studies , 2007, BMC Genomics.

[9]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[10]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[11]  Stuart Macgregor,et al.  Most pooling variation in array-based DNA pooling is attributable to array error rather than pool construction error , 2007, European Journal of Human Genetics.

[12]  Rebecca F. Halperin,et al.  Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. , 2007, American journal of human genetics.

[13]  A. Goodman.  Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease , 2006, Journal of cellular physiology.

[14]  L. Fratiglioni,et al.  Role of genes and environments for explaining Alzheimer disease. , 2006, Archives of general psychiatry.

[15]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[16]  G. Kirov,et al.  BMC Genomics BioMed Central Methodology article Pooled DNA genotyping on Affymetrix SNP genotyping arrays , 2006 .

[17]  D. Clayton,et al.  Genome-wide association studies: theoretical and practical concerns , 2005, Nature Reviews Genetics.

[18]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[19]  P. So,et al.  Disruption of the retinoid signalling pathway causes a deposition of amyloid β in the adult rat brain , 2004, The European journal of neuroscience.

[20]  P. McKeigue,et al.  Problems of reporting genetic associations with complex outcomes , 2003, The Lancet.

[21]  A. Pardee,et al.  Evidence for defective retinoid transport and function in late onset Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. O’Donovan,et al.  DNA Pooling: a tool for large-scale association studies , 2002, Nature Reviews Genetics.

[23]  G. Kirov,et al.  Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools , 2002, Human Genetics.

[24]  L. Cardon,et al.  Association study designs for complex diseases , 2001, Nature Reviews Genetics.

[25]  Michael Owen,et al.  Cheap, accurate and rapid allele frequency estimation of single nucleotide polymorphisms by primer extension and DHPLC in DNA pools , 2000, Human Genetics.

[26]  N. Risch.  Searching for genetic determinants in the new millennium , 2000, Nature.

[27]  E M Wijsman,et al.  The number of trait loci in late-onset Alzheimer disease. , 2000, American journal of human genetics.

[28]  P. Lantos,et al.  Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies , 1999, British Journal of Psychiatry.

[29]  R. Bucks,et al.  Assessment of activities of daily living in dementia: development of the Bristol Activities of Daily Living Scale. , 1996, Age and ageing.

[30]  J. Haines,et al.  Apolipoprotein E genotype in patients with alzheimer's disease: Implications for the risk of dementia among relatives , 1995, Annals of neurology.

[31]  M. Pericak-Vance,et al.  Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.

[32]  G. Alexopoulos,et al.  Cornell scale for depression in dementia , 1988, Biological Psychiatry.

[33]  B. Reisberg,et al.  Global Deterioration Scale (GDS). , 1988, Psychopharmacology bulletin.

[34]  F. Huppert,et al.  CAMDEX: A Standardised Instrument for the Diagnosis of Mental Disorder in the Elderly with Special Reference to the Early Detection of Dementia , 1986, British Journal of Psychiatry.

[35]  J. Yesavage,et al.  A knowledge assessment test for geriatric psychiatry. , 1985, Hospital & community psychiatry.

[36]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[37]  M. Roth,et al.  The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.

[38]  Webster Dd,et al.  Critical analysis of the disability in Parkinson's disease. , 1968 .

[39]  D. Webster.  Critical analysis of the disability in Parkinson's disease. , 1968, Modern treatment.